Diabetes

FAF May Help Determine Need for Additional PRP in Proliferative DR

Study finds partially preserved photoreceptor integrity and sensitivity even in laser-treated areas of the retina.
07/17/2024

UWF-FA Reveals DR Progression Associated with Nonperfusion

Neovascularization, however, was less strongly correlated with disease advancement in a large retrospective review of over one thousand images.
07/12/2024

MD Groups Respond to Study Linking GLP-1 Treatment to NAION

The American Academy of Ophthalmology and North American Neuro-Ophthalmology Society stress that more research is needed to determine whether the association is causal.
07/11/2024

Popular Type 2 Diabetes Drug Associated with Increased Risk of NAION

Though causality could not be determined, researchers observed a higher incidence of the event among patients on GLP-1 receptor agonists than those taking other diabetes or weight loss medications.
07/08/2024

Over Four Million People Globally Experience Vision Impairment from DR

One-quarter of those affected are now blind, says a new meta-analysis. Prevalence is disproportionately higher in low-income regions and female populations.
07/02/2024

Meta-analysis Says Oral Hypoglycemic Not Clearly Linked to Increased DR Risk

Studies on dipeptidyl peptidase-4 inhibitor use showed conflicting evidence and, ultimately, no significant change in risk or progression in patients with diabetes.
07/02/2024

Controlling Hypertension Could Help Delay DR

A small study found that high blood pressure plays a large role in driving retinal arteriolar wall thickening in preclinical diabetic retinopathy.
06/19/2024

Study Documents Increased DR Prevalence in Young Patients and Minorities

People aged 20 to 39 and those in Hispanic or Black ethnic/racial groups were most acutely affected, supporting the need for DR screening in young adults.
06/18/2024

Diabetic Eye Disease: A Comprehensive Look at the Optometrist’s Role

Learn what to pay attention to and when to take charge.
06/15/2024

Type 2 Diabetes Drug May Reduce RVO Risk

Compared with DPP-4i, patients taking SGLT-2i had a significantly lower incidence of retinal vein occlusion, particularly branch RVO.
06/14/2024

Upcoming Events

July 24, 2024

Rethinking Dry Eye Disease: A Contemporary Approach to a Complex Condition
Location: Virtual
Presenters: Jade Coats, OD, and Neel Vaidya, MD, MPH
Webinar: 9:00pm ET

Sponsored by Bausch + Lomb

Register here

August 14, 2024

The 3 I's of Geographic Atrophy: Imaging, Identification, and Intervention
Location: Virtual
Presenters:  Mark Dunbar, OD, FAAO, and David Chin Yee, MD
Webinar: 8:30pm ET


Sponsored by Apellis

Register here

August 20, 2024

Rethinking Dry Eye Disease: A Contemporary Approach to a Complex Condition
Location: Virtual
Presenters: Joshua Davidson, OD, and Zaina Al-Mohtaseb, MD
Webinar: 8:00pm ET

Sponsored by Bausch + Lomb

Register here